CNBC's newest documentary, featuring Melissa Lee, "Big Shot: The Ozempic Revolution," provides an in-depth look at how a diabetes drug reinvented weight loss culture and the way we treat obesity in America. In this one-hour program, CNBC takes a deep dive into the global anti-obesity drug market, exploring the risks people are taking to get their hands on these drugs. It examines the role of compounding pharmacies and telehealth services competing to meet the demand and capture a share of the market. CNBC's Lee profiles doctors, patients and gets a rare look inside the global juggernaut, Novo Nordisk, and other prominent companies to examine these cutting-edge medications and their greater impact on the economy.

HOSTED BY

Melissa Lee @MelissaLeeCNBC